FMRP: a triple threat to PSD-95 by Cara J. Westmark
GENERAL COMMENTARY
published: 30 April 2013
doi: 10.3389/fncel.2013.00057
FMRP: a triple threat to PSD-95
Cara J. Westmark*
Department of Neurology, University of Wisconsin, Madison, WI, USA
*Correspondence: westmark@wisc.edu
Edited by:
Hansen Wang, University of Toronto, Canada
Reviewed by:
Hansen Wang, University of Toronto, Canada
Gary J. Bassell, Emory University, USA
Laurie Doering, McMaster University, Canada
A commentary on
Multiple autism-linked genes mediate
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Cowan, C. W., and Huber, K. M. (2012).
Cell 151, 1581–1594.
Autism is a spectrum of developmen-
tal disorders characterized by deficits in
verbal and non-verbal communication,
social awareness and interactions, and
imaginative play (Caronna et al., 2008).
There is a strong genetic basis for autism,
which is highly comorbid with single-
gene disorders including fragile X syn-
drome (FXS) (Wang et al., 2010). The
main challenges that have plagued the
field include accurate and early diagno-
sis, identifying susceptibility genes, defin-
ing the cellular andmolecularmechanisms
through which genetic mutations confer
disease risk and phenotypes, and improv-
ing interventions and treatments. In their
Cell article, Tsai and colleagues provide
a mechanistic framework explaining how
multiple autism-related genes cooperate
in experience-dependent synapse elimi-
nation and how that mechanism fails
in FXS (Tsai et al., 2012). Their results
strongly support the contention that
bypassing proteasome-mediated degrada-
tion of postsynaptic density protein 95
(PSD-95) contributes to altered synaptic
plasticity in autism.
Synaptic plasticity is the biological
basis for learning and memory and
occurs at the postsynaptic density (PSD),
a protein dense region at the postsy-
naptic membrane of excitatory synapses
(Sheng and Hoogenraad, 2007). The PSD
concentrates and organizes hundreds of
proteins including membrane receptors,
signaling molecules, and scaffolding pro-
teins. In response to synaptic activity,
this dynamic region undergoes struc-
tural changes that result in the forma-
tion or elimination of dendritic spines.
Synapse formation and pruning are critical
for synaptic plasticity; yet, the molecu-
lar mechanisms that regulate these pro-
cesses have remained elusive. Tsai and
colleagues elegantly demonstrate roles for
several autism-related molecules includ-
ing myocyte enhancer factor 2 (MEF2),
protocadherin 10 (Pcdh10), and fragile
X mental retardation protein (FMRP)
in a proteasome-mediated pathway that
degrades PSD-95 and leads to synapse
elimination (Tsai et al., 2012).
PSD-95 is a major PSD scaffolding
protein with established roles in mod-
ulating N-methyl-D-aspartate receptor
(NMDAR) signaling, α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid
receptor (AMPAR) endocytosis, dendritic
spine stabilization, and synaptic strength
(Keith and El-Husseini, 2008; Woods et al.,
2012). PSD-95 abundance is a culmination
of protein synthesis, transport, and degra-
dation processes all occurring locally at
synapses. PSD-95 synthesis at synapses is
regulated through group 1 metabotropic
glutamate receptors (mGluR), FMRP,
and microRNA-125a (miR-125a) (Todd
et al., 2003; Muddashetty et al., 2012)
while degradation occurs via proteasomes
after protein ubiquitination by the E3
ligase murine double minute 2 (Mdm2)
(Colledge et al., 2003). Tsai and colleagues
demonstrate that activation of MEF2
results in a significant decrease in PSD-
95, which is due to protein degradation
and not reduced protein synthesis.
The MEF2 family of transcription fac-
tors is highly expressed in brain and key
regulators of activity-dependent synapse
elimination and learning-induced struc-
tural plasticity (Flavell et al., 2006; Cole
et al., 2012). MEF2C is the major isoform
involved in hippocampal synaptic func-
tion (Akhtar et al., 2012), and mutations
in the gene occur in 1% of patients with
moderate to severe intellectual disability
and 2% of patients with Rett syndrome
(Zweier and Rauch, 2011). The MEF2 pro-
teins bind to synaptic activity-responsive
elements (SARE), which are significantly
enriched in genes that encode mRNAs tar-
geted by FMRP (Rodríguez-Tornos et al.,
2013). Tsai and colleagues identified the
autism-related gene Pcdh10 (Redies et al.,
2012) in both a genome-wide screen of
MEF2 transcriptional targets (Flavell et al.,
2008) and as an FMRP mRNA target
(Darnell et al., 2011). They then con-
firmed that MEF2 activates transcription
of Pcdh10 and that FMRP associates with
Pcdh10mRNA. Pcdh10 encodes a cadherin
superfamily protein whose levels change
in response to neuronal activity (Morrow
et al., 2008), but little was known regard-
ing its function. The authors demonstrate
that Pcdh10 is present in spines and at the
excitatory synapses and functions to asso-
ciate ubiquitinated PSD-95 with the pro-
teasome. The degradation of PSD-95 by
proteasomes leads to synapse elimination.
This MEF2-, Pcdh10-, Mdm2-
dependent pathway for ubiquitin-depen-
dent, proteasome-mediated degradation
of PSD-95 goes awry in the absence
of FMRP. FMRP is an mRNA binding
protein absent or mutated in FXS, a dis-
order characterized by excessive immature
dendritic spines suggesting a deficit in
excitatory synapse elimination (Comery
et al., 1997). In response to neuronal activ-
ity, MEF2 is activated and induces rapid
and robust synapse elimination in wild
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type, but fails to eliminate synapses in
Fmr1KO hippocampal neurons (Pfeiffer
et al., 2011). Tsai and colleagues show
robust MEF2-activated transcription of
Pchd10 and elevated basal translation of
Pchd10 in Fmr1KO indicating that FMRP
functions downstream of MEF2. They
further demonstrate that Fmr1KO neu-
rons exhibit deficits in ubiquitination and
degradation of PSD-95 due to decreased
colocalization of and interaction between
Mdm2 and PSD-95. There is increased
interaction between elongation factor 1
alpha (EF1α) and Mdm2 in Fmr1KO mice
and when EF1α is bound to Mdm2 the
latter loses its ability to bind to PSD-95.
EF1α is an FMRP target mRNA and its
protein levels are upregulated in Fmr1KO
brain. Thus, in the absence of FMRP, EF1α
is overexpressed and sequesters Mdm2
resulting in decreased ubiquitination and
FIGURE 1 | Fragile X mental retardation protein (FMRP) poses a triple threat to postsynaptic
density protein 95 (PSD-95) levels at the synapse. (1) FMRP binds directly to a guanine (G)-rich
sequence within the 3’-untranslated region (UTR) of PSD-95 mRNA to regulate mRNA stability
(Zalfa et al., 2010). (2) Phosphorylated FMRP recruits Argonaute 2 (AGO2) and microRNA-125a
(miR-125a) into an inhibitory complex on PSD-95 mRNA that blocks translation (Muddashetty et al.,
2012). Group 1 mGluR stimulation with (S)-3,5-dihydroxyphenylglycine (DHPG) leads to
dephosphorylation of FMRP, release of AGO2 from the mRNA and activation of translation. And (3)
myocyte enhancer factor 2 (MEF2) induces ubiquitination of PSD-95 by the E3 ligase murine double
minute 2 (Mdm2), which allows for the association of PSD-95 with protocadherin 10 (Pcdh10) and
proteasomes. The degradation of PSD-95 by proteasomes leads to synaptic pruning (Tsai et al.,
2012). However, in the absence of FMRP, elongation factor 1 alpha (EF1α) is overexpressed and
sequesters Mdm2 resulting in decreased ubiquitination (U) and degradation of PSD-95. It remains
to be determined how the multiple functions of FMRP are coordinated in a cell- and/or brain
region-specific manner to control synpatic levels of PSD-95.
degradation of PSD-95. The authors con-
clude their study by demonstrating EF1α
knockdown in Fmr1KO neurons restores
MEF2-induced synaptic localization of
Mdm2, interaction between Mdm2 and
PSD-95, PSD-95 degradation and robust
synapse elimination. Interestingly, PSD-95
is associated with Williams and Angelman
syndromes further establishing a link
with multiple neurodevelopmental disor-
ders (Feyder et al., 2010; Cao et al., 2013).
The Centers for Disease Control esti-
mate autism rates at 1 in 50 school-age
children (Blumberg and Bramlett, 2013).
It is imperative to understand the under-
lying cellular and molecular mechanisms
in order to design better therapeutics for
this epidemic. Tsai and colleagues uncover
an integrated process of transcriptional,
translational, and protein turnover events
through which the activity-dependent
transcription factor MEF2 refines synap-
tic connections in wild type neurons and
how that process fails in Fmr1KO. During
their studies, the authors define a novel,
albeit indirect, role for FMRP in modu-
lating PSD-95 degradation. The conver-
gence of multiple autism-related genes at
the level of PSD-95 degradation defines
a pivotal pathway that controls synap-
tic pruning. It remains to be determined
how additional functions of FMRP in
regards to PSD-95, i.e., mRNA stabiliza-
tion and translational inhibition, affect
synapse remodeling (Figure 1).
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